Testosterone topical - Novavax
Alternative Names: ESP 210Latest Information Update: 13 Nov 2021
At a glance
- Originator Novavax
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone agonists; Testosterone congener stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Female sexual dysfunction; Hypogonadism
Most Recent Events
- 25 Oct 2007 Novavax and Allergan terminate their licensing agreement for testosterone topical lotion
- 18 Oct 2007 Esprit Pharma has been acquired by Allergan
- 19 May 2006 Testosterone topical lotion has been licensed to Esprit Pharma in North America